# Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

> **NCT04524507** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 56 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** High-titer Convalescent COVID-19 Plasma (CCP1)
- **BIOLOGICAL:** Standard-titer Convalescent COVID-19 plasma (CCP2)

## Key facts

- **NCT ID:** NCT04524507
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-27
- **Primary completion:** 2021-01-04
- **Final completion:** 2021-06-04
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04524507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04524507, "Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04524507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*